Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.

Slides:



Advertisements
Similar presentations
Liver Transplant Outcomes in the United States : Effect of Preservation Solution DKFC Symposium July 16, 2012 John Fung, MD, PhD Cleveland Clinic Disclosure:
Advertisements

HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University
HEART TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
What makes a pancreas allograft marginal? Peter J Friend University of Oxford.
Impact of expanded criteria donors on patient survival after heart, lung, liver and combined organ transplantation Quebec experience from 2003 to 2009.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
The Deceased Donor Kidney Allocation System
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Table SA-1: Number of Kidney Transplants by Donor Type and Re-Transplant Status Source: Canadian Organ Replacement Register, 2014, CIHI *Missing data for.
ESRD Prognosis ERA-EDTA vs. Danish Renal Registry James Heaf.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
© ANZOD Registry Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the.
Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.
A Mission to Save More Lives Where we’ve been, where we are, and where we need to be Thomas A. Nakagawa, M.D, FAAP, FCCM Professor, Anesthesiology and.
Allocation of elderly deceased donor kidneys Lisa Bradbury, Niaz Ahmad, Paul Gibbs, Richard Baker, Adam McLean, Chris Callaghan Renal Transplant Services.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
Eurotransplant: An example of success for cross-border cooperation Bruno Meiser Eurotransplant International Foundation, Leiden, Netherlands Dept. of Cardiac.
Comparison of HTK and UW in Abdominal Transplantation Dr. Richard S. Mangus, MD MS Indiana University, School of Medicine.
A Guide to the Scientific Registry of Transplant Recipients Organ Procurement Organization Reports
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Monitoring HLA-specific antibodies
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
The New Kidney Allocation System Gautham Mogilishetty, MD Associate Professor of Medicine Division of Nephrology and Transplantation University of Cincinnati.
PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo.
Johannesburg Region Allocation of Deceased Donor Kidneys Controversies Meeting 7-8 May 2011 Prof R.S.Britz and Nephrology Panel Kim Crymble Transplant.
Israel David and Michal Moatty-Assa The Search for Compatible Organs – A Handy Aid.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.
The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.
HEART-LUNG TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
Interobserver Reliability of Acute Kidney Injury Network (AKIN) criteria A single center cohort study Figure 2 The acute kidney injury network (AKIN) criteria.
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
DONOR RISK INDEX-LIVER GRAFT SURVIVAL ASSOCIATION IN PATIENTS OVER 18 YEARS OF AGE IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths.
Is BMI a Justified Contraindication for Kidney Transplantation? Introduction OHSU’s Kidney Transplant Program has set a BMI >35 kg/m 2 as a relative contraindication.
When Using SRTR Slides. SRTR Slide Use Guidelines.
Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.
Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan.
Scottish Renal Registry Report 2009 Section D - Kidney Transplantation Published by the Information Services Division (ISD Scotland), Common Services Agency.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
STUDY OF THE RISK FACTORS OF ACUTE REJECTION AFTER LIVE DONOR RENAL TRANSPLANTATION:A SINGLE EGYPTIAN CENTER EXPERIENCE Ayman M Nagib¹, Ahmed S Elsaied¹,
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL R2 이윤정 Richard A. Belkin, Noreen R. Henig, Lianne G. Singer, Cecilia Chaparro,
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
Kidney Graft Survival Rates do not improve by era: the impact of factor “Age” E. Bertoni MD, A. Larti MD, G. Rosso MD and M. Salvadori MD Renal Unit –
Living Donor Transplants
Enterprise | Interest Nothing to disclose.
Number of transplants, by donor type figure 8.1
Renal transplants in Scandiatransplant
C. Chalklin, C. Colmont, A. Zaidi, J. Warden-Smith, E. Ablorsu
Liver only transplants in the UK Question 2: In terms of survival benefit.
Kidney allocation to highly sensitized patients
HLA Compatibility and Heart Transplant Survival Using A Validated Matching Algorithm Andrew L. Rivard, MD, MS, Cleveland Clinic Abu Dhabi Naoru Koizumi,
Risk factors in deceased-donor transplants Risk factor 1988
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Introduction to Kidney Donor Risk Index (DRI)
Number of Donors in Australia
Number of Donors in Australia
Presentation transcript:

Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients of kidney transplantation

Introduction Expanded criteria donors (ECD) represent a large proportion of our total population of organ donors. The use of marginal or ECD has become a common clinical practice because of the gap between the number of candidate for renal transplantation and the number of donor available.

Objective The objective of the present study is to compare outcomes of patients who underwent kidney transplantation with ECD versus standard criteria donors (SCD) in our patient population Ensemble pour le don d'organesTransplant Québec3

Source: 2009 OPTN/SRTR Annual Report, Tables 5.14a, b, d. Figure III-6. Unajusted 1-Year ( ), 5-Year ( ) and 10-Year ( ) Kidney Recipient Survival, by Donor Type

Methods Retrospective review of donors used for organ transplantation from 2003 to Analyses of patient survival and of graft survival with a clinical follow up until may Patient and graft survival were studied with uni and multivariate methods in regard to the effect of donor and recipients characteristics.

Methods We studied 792 deceased donors and 1375 adult recipients of kidney transplants in six Quebec centers between 2003 and Mean follow-up period was 3.5 ± 2 years Ensemble pour le don d'organesTransplant Québec6

Donors characteristics DONORS Standard criteria 510 donors (64%) Extended criteria 282 donors (36%) P AGE (years)39 ± 1465 ± Gender298 (58%) M 212 (42%) W 135 (48%) M 147 (52%) W Weight (kg)72 ± 1976 ± Causes of death CVA vs others 229 (45%) vs 281 (55%) 242 (86%) vs 40 (14%) Serum creatinine (mmol/l) 77 ± 4575 ± Ensemble pour le don d'organesTransplant Québec7

Recipients characteristics RECIPIENTS Standard criteria 919 recipients Extended criteria 456 recipients P AGE (years)49 ± 1356 ± Waiting time to transplantation (days) 771 ± ± HLA DR mismatch0: 357 1: 311 2: 251 0: 155 1: 146 2: Ensemble pour le don d'organesTransplant Québec8

Patient survival after kidney transplantation Extended versus standard donor criteria P = 0.47

Patient survival after transplantation Multivariate analyses (Cox) of risk factors DONORSRELATIVE RISK Confidence limits 95% P Age (years) Creatinine (mmol/L) Female gender * Extended criteria donors RECIPIENTS Age at transplantation * Waiting time (days) * No of HLA DR mismatches

Graft survival Extended versus standard donor criteria P = 0.28

Graft survival Multivariate analyses (Cox) of risk factors DONORSRELATIVE RISK Confidence limits 95% P Age (years) * Creatinine (mmol/l) Female gender Extended criteria donors RECIPIENTS Age at transplantation * Waiting time (days) * No of HLA DR mismatches

Interpretation of results Patient and graft survival were excellent at short term follow-up after kidney transplantation with both standard and extended donor criteria. Risk factors for patient death after kidney transplantation were donor female gender, recipient age and waiting time to transplantation. Risk factors for graft loss were donor and recipient age and waiting time to transplantation.

Conclusion The present study showed that the actual definition of ECD had no effect on patient and graft survival 5 years after transplantation in our patient population Ensemble pour le don d'organesTransplant Québec14

Thanks to all co-autors and collaborators: University of Montréal: Dr A. Boucher, Dr R. Dandavino, Dr M. Paquet McGill Univeristy: Dr M. Cantarovich University of Sherbrooke: Dr Wolff Laval University: DR I. Houde

Graft survival Donors < 65 years versus ≥ 65 years